{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:13:27Z","timestamp":1784837607768,"version":"3.55.0"},"reference-count":134,"publisher":"Elsevier","isbn-type":[{"value":"9780323988537","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acc.2022.06.001","type":"book-chapter","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T19:27:50Z","timestamp":1661974070000},"page":"1-35","source":"Crossref","is-referenced-by-count":10,"title":["Long non-coding RNA in Non-alcoholic fatty liver disease"],"prefix":"10.1016","member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2022.06.001_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Ara\u00fajo","year":"2018","journal-title":"Liver Int."},{"issue":"6 Pt 2","key":"10.1016\/bs.acc.2022.06.001_bb0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1262-3636(08)74597-X","article-title":"Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis","volume":"34","author":"Serfaty","year":"2008","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12664-020-01018-x","article-title":"Epidemiology of non-alcoholic fatty liver disease in Asia","volume":"39","author":"Wong","year":"2020","journal-title":"Indian J. Gastroenterol."},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0025","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"17","key":"10.1016\/bs.acc.2022.06.001_bb0035","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0045","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2011.04145.x","article-title":"The epidemiology, pathogenesis and histopathology of fatty liver disease","volume":"61","author":"Levene","year":"2012","journal-title":"Histopathology"},{"issue":"14","key":"10.1016\/bs.acc.2022.06.001_bb0060","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question","volume":"21","author":"Streba","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/bs.acc.2022.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0070","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/DMSO.S67400","article-title":"Mechanism linking diabetes mellitus and obesity","volume":"4","author":"Al-Goblan","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1079\/PNS19750044","article-title":"Hormonal control of adipose tissue lipolysis","volume":"34","author":"Siddle","year":"1975","journal-title":"Proc. Nutr. Soc."},{"issue":"18","key":"10.1016\/bs.acc.2022.06.001_bb0090","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/bs.acc.2022.06.001_bb0105","doi-asserted-by":"crossref","first-page":"925807","DOI":"10.1155\/2012\/925807","article-title":"Nutrition and nonalcoholic fatty liver disease: the significance of cholesterol","volume":"2012","author":"Enjoji","year":"2012","journal-title":"Int. J. Hepatol."},{"issue":"10","key":"10.1016\/bs.acc.2022.06.001_bb0110","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","author":"Hirsova","year":"2016","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/bs.acc.2022.06.001_bb0115","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0130","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0135","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0145","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","article-title":"Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.hepres.2005.09.032","article-title":"Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome","volume":"33","author":"Ueki","year":"2005","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2005.04.004","article-title":"Signalling links in the liver: knitting SOCS with fat and inflammation","volume":"43","author":"Farrell","year":"2005","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/bs.acc.2022.06.001_bb0165","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI114362","article-title":"Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors","volume":"84","author":"Friedman","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0180","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","article-title":"Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C","volume":"26","author":"Tanwar","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0195","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0016-5085(79)80170-5","article-title":"Collagen types in normal and cirrhotic liver","volume":"76","author":"Rojkind","year":"1979","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinbiochem.2015.07.019","article-title":"Hyaluronic acid as a non-invasive biomarker of liver fibrosis","volume":"49","author":"Neuman","year":"2016","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0205","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/bs.acc.2022.06.001_bb0210","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","volume":"68\u201369","author":"Roderfeld","year":"2018","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0215","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1053\/jhep.2000.20521","article-title":"Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model","volume":"32","author":"Yoshiji","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","article-title":"Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage","volume":"1791","author":"Blaner","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.acc.2022.06.001_bb676","doi-asserted-by":"crossref","unstructured":"N. Roehlen, E. Crouchet, T.F. Baumert, Liver fibrosis: mechanistic concepts and therapeutic perspectives, Cell 9 (4) (2020) 875 PMID: 32260126; PMCID: PMC7226751, doi:10.3390\/cells9040875.","DOI":"10.3390\/cells9040875"},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000444550","article-title":"Development and regression of cirrhosis","volume":"34","author":"Saffioti","year":"2016","journal-title":"Dig. Dis."},{"issue":"16","key":"10.1016\/bs.acc.2022.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000491428","article-title":"The pattern of elevated liver function tests in nonalcoholic fatty liver disease predicts fibrosis stage and metabolic-associated comorbidities","volume":"37","author":"Shirin","year":"2019","journal-title":"Dig. Dis."},{"issue":"85","key":"10.1016\/bs.acc.2022.06.001_bb0240","first-page":"1433","article-title":"Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk","volume":"55","author":"Tahan","year":"2008","journal-title":"Hepato-Gastroenterology"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0245","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0250","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0255","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0260","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography","volume":"32","author":"de L\u00e9dinghen","year":"2012","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0265","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0270","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0275","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0280","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"5675","key":"10.1016\/bs.acc.2022.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1098119","article-title":"Ultraconserved elements in the human genome","volume":"304","author":"Bejerano","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"issue":"264","key":"10.1016\/bs.acc.2022.06.001_bb0300","doi-asserted-by":"crossref","first-page":"118560","DOI":"10.1016\/j.lfs.2020.118560","article-title":"Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease","volume":"1","author":"Rohilla","year":"2021","journal-title":"Life Sci."},{"issue":"60","key":"10.1016\/bs.acc.2022.06.001_bb0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40781-018-0183-7","article-title":"Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review","volume":"25","author":"Dhanoa","year":"2018","journal-title":"J. Anim. Sci. Technol."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0310","doi-asserted-by":"crossref","first-page":"447","DOI":"10.18632\/oncotarget.178","article-title":"Natural antisense transcript: a concomitant engagement with protein-coding transcript","volume":"1","author":"Li","year":"2010","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0315","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.acc.2022.06.001_bb0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ultras.2016.03.001","article-title":"Experimental study of nonlinear ultrasonic behavior of soil materials during the compaction","volume":"69","author":"Chen","year":"2016","journal-title":"Ultrasonics"},{"issue":"8","key":"10.1016\/bs.acc.2022.06.001_bb0325","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tig.2014.06.001","article-title":"Transcriptional regulatory functions of nuclear long noncoding RNAs","volume":"30","author":"Vance","year":"2014","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2013.10.002","article-title":"Long noncoding RNAs: fresh perspectives into the RNA world","volume":"39","author":"Yang","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0335","first-page":"34","article-title":"Long non-coding RNAs in liver cancer and nonalcoholic steatohepatitis","volume":"6","author":"Uchida","year":"2020","journal-title":"Noncoding RNA"},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0340","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrg3355","article-title":"RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond","volume":"14","author":"Castel","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0345","doi-asserted-by":"crossref","first-page":"35531","DOI":"10.1038\/srep35531","article-title":"LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)","volume":"19","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0350","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41467-018-03072-8","article-title":"Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195\/miR4668 maturation","volume":"9","author":"Guo","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/bs.acc.2022.06.001_bb0355","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1002\/jcp.29795","article-title":"Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXR\u03b1 transcription","volume":"235","author":"Huang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/bs.acc.2022.06.001_bb0360","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.18632\/aging.103020","article-title":"Ultraconserved element uc.333 increases insulin sensitivity by binding to miR-223","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"17","key":"10.1016\/bs.acc.2022.06.001_bb0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12986-020-0430-z","article-title":"LncRNA Gm12664-001 ameliorates nonalcoholic fatty liver through modulating miR-295-5p and CAV1 expression","volume":"4","author":"Zhang","year":"2020","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0370","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1194\/jlr.RA120000664","article-title":"The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice","volume":"61","author":"Ma","year":"2020","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0375","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cbf.3495","article-title":"Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease","volume":"38","author":"Li","year":"2020","journal-title":"Cell Biochem. Funct."},{"issue":"9","key":"10.1016\/bs.acc.2022.06.001_bb0380","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fphar.2018.00888","article-title":"LncRNA-AK012226 is involved in fat accumulation in db\/db mice fatty liver and Non-alcoholic fatty liver disease cell model","volume":"8","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0385","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12967-021-02769-7","article-title":"LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[formula: see text]B\/JNK pathway by endoplasmic reticulum stress","volume":"19","author":"Ye","year":"2021","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0390","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/jcmm.14818","article-title":"Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/bs.acc.2022.06.001_bb0395","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181722","article-title":"LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a\/PPAR\u03b3 axis in non-alcoholic fatty liver disease","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0400","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/hep.29034","article-title":"A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis","volume":"66","author":"Atanasovska","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0405","doi-asserted-by":"crossref","first-page":"22640","DOI":"10.1038\/srep22640","article-title":"Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability","volume":"3","author":"Yan","year":"2016","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/bs.acc.2022.06.001_bb0410","first-page":"7883","article-title":"HOTAIR participates in hepatic insulin resistance via regulating SIRT1","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0415","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcb.26317","article-title":"Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR\/S6K1 signaling pathway","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/bs.acc.2022.06.001_bb0420","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1002\/jcp.28450","article-title":"Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease","volume":"234","author":"Shen","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0425","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/db17-0799","article-title":"Long noncoding RNA lncSHGL recruits hnRNPA1 to suppress hepatic gluconeogenesis and lipogenesis","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"issue":"700","key":"10.1016\/bs.acc.2022.06.001_bb0430","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.gene.2019.02.096","article-title":"Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p","volume":"5","author":"Zhang","year":"2019","journal-title":"Gene"},{"issue":"10","key":"10.1016\/bs.acc.2022.06.001_bb0435","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1096\/fj.201900643RRR","article-title":"Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2022.06.001_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2019.01.018","article-title":"LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6","volume":"94","author":"Huang","year":"2019","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0445","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0450","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","article-title":"RNA therapeutics: beyond RNA interference and antisense oligonucleotides","volume":"11","author":"Kole","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/bs.acc.2022.06.001_bb0455","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1073\/pnas.1817669116","article-title":"DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis","volume":"116","author":"Graham","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0460","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0465","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41467-018-05383-2","article-title":"Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0470","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms18010021","article-title":"Long non-coding RNA profiling in a non-alcoholic fatty liver disease rodent model: new insight into pathogenesis","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/bs.acc.2022.06.001_bb0480","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12967-015-0383-6","article-title":"Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles","volume":"27","author":"Yuan","year":"2015","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0485","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1159\/000495384","article-title":"ATP citrate Lyase and LncRNA NONMMUT010685 play crucial role in nonalcoholic fatty liver disease based on analysis of microarray data","volume":"51","author":"Ma","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"14","key":"10.1016\/bs.acc.2022.06.001_bb0490","doi-asserted-by":"crossref","first-page":"22917","DOI":"10.18632\/oncotarget.15286","article-title":"Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease","volume":"8","author":"Sookoian","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/bs.acc.2022.06.001_bb0495","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/liv.14167","article-title":"Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity","volume":"39","author":"Di Mauro","year":"2019","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0500","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1159\/000501851","article-title":"Rodent models of nonalcoholic fatty liver disease","volume":"101","author":"Zhong","year":"2020","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0505","first-page":"41","article-title":"Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models","author":"Green","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0510","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2018.03.127","article-title":"Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt\/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis","volume":"499","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0515","doi-asserted-by":"crossref","first-page":"30709","DOI":"10.1038\/srep30709","article-title":"Characterization of long non-coding RNA transcriptome in high-energy diet induced nonalcoholic steatohepatitis minipigs","volume":"28","author":"Xia","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/bs.acc.2022.06.001_bb0520","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1002\/jcp.29795","article-title":"Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXR\u03b1 transcription","volume":"235","author":"Huang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0525","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10238-020-00636-1","article-title":"LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2","volume":"20","author":"Yang","year":"2020","journal-title":"Clin. Exp. Med."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0530","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/hep.27043","article-title":"Long noncoding RNA in liver diseases","volume":"60","author":"Takahashi","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0535","first-page":"18","article-title":"The role of long Non-coding RNAs (lncRNAs) in the development and progression of fibrosis associated with nonalcoholic fatty liver disease (NAFLD)","volume":"4","author":"Hanson","year":"2018","journal-title":"Noncoding RNA."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0540","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes Sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0545","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-020-02225-y","article-title":"Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2\/AKT pathway","volume":"18","author":"Chi","year":"2020","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0550","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI95802","article-title":"Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer","volume":"128","author":"Jeong","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0555","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12072-017-9841-y","article-title":"Pathogenesis of non-alcoholic fatty liver disease mediated by YAP","volume":"12","author":"Chen","year":"2018","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0560","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(00)80711-4","article-title":"A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex","volume":"97","author":"Lanz","year":"1999","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.acc.2022.06.001_bb0565","first-page":"E230","article-title":"Plasma long noncoding RNA LeXis is a potential diagnostic marker for non-alcoholic steatohepatitis","volume":"10","author":"Park","year":"2020","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/bs.acc.2022.06.001_bb0570","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10238-020-00636-1","article-title":"LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2","volume":"20","author":"Yang","year":"2020","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0575","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41467-017-02229-1","article-title":"The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation","volume":"8","author":"Du","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0580","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cmet.2010.10.005","article-title":"PER2 controls lipid metabolism by direct regulation of PPAR\u03b3","volume":"12","author":"Grimaldi","year":"2010","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0585","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/genes11050545","article-title":"Expression of the long noncoding RNA GAS5 correlates with liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"11","author":"Han","year":"2020","journal-title":"Genes (Basel)"},{"issue":"47","key":"10.1016\/bs.acc.2022.06.001_bb0590","doi-asserted-by":"crossref","first-page":"28286","DOI":"10.1074\/jbc.M115.683813","article-title":"Non-coding RNA growth arrest-specific transcript 5 (GAS5) inhibits liver fibrogenesis through a mechanism of competing endogenous RNA","volume":"290","author":"Yu","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/bs.acc.2022.06.001_bb0595","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/physiolgenomics.00045.2012","article-title":"Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression","volume":"44","author":"Imai","year":"2012","journal-title":"Physiol. Genomics"},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0600","doi-asserted-by":"crossref","first-page":"9698","DOI":"10.1002\/jcp.27656","article-title":"H19\/miR-148a\/USP4 axis facilitates liver fibrosis by enhancing TGF-\u03b2 signaling in both hepatic stellate cells and hepatocytes","volume":"234","author":"Zhu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molmet.2016.10.010","article-title":"Conserved function of the long noncoding RNA Blnc1 in brown adipocyte differentiation","volume":"6","author":"Mi","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/bs.acc.2022.06.001_bb0610","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2017.09.001","article-title":"Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells","volume":"190","author":"Leti","year":"2017","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/bs.acc.2022.06.001_bb0615","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/hep4.1184","article-title":"Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage","volume":"2","author":"Sookoian","year":"2018","journal-title":"Hepatol. Commun."},{"issue":"24","key":"10.1016\/bs.acc.2022.06.001_bb0620","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1080\/15384101.2015.1120917","article-title":"MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis","volume":"14","author":"Yu","year":"2015","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0625","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2015.09.028","article-title":"Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion","volume":"289","author":"Wu","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/bs.acc.2022.06.001_bb0630","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.39061","article-title":"The histone deacetylase Sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor \u03b2 signaling","volume":"67","author":"Wei","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2022.06.001_bb0635","doi-asserted-by":"crossref","DOI":"10.1080\/16546628.2017.1412794","article-title":"Up-regulated HOTAIR induced by fatty acids inhibits PTEN expression and increases triglycerides accumulation in HepG2 cells","author":"Li","year":"2017","journal-title":"Food Nutr. Res."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0640","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymthe.2016.10.015","article-title":"HOTAIR epigenetically modulates PTEN expression via microRNA-29b: a novel mechanism in regulation of liver fibrosis","volume":"25","author":"Yu","year":"2017","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/bs.acc.2022.06.001_bb0645","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbadis.2016.12.009","article-title":"Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver","volume":"1863","author":"Bian","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"2","key":"10.1016\/bs.acc.2022.06.001_bb0650","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2019.06.104","article-title":"LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK\/SREBP-1 signaling","volume":"516","author":"Sun","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/bs.acc.2022.06.001_bb0655","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-018-0838-5","article-title":"Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/bs.acc.2022.06.001_bb0660","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00109-017-1586-5","article-title":"NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6","volume":"95","author":"Yu","year":"2017","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/bs.acc.2022.06.001_bb677","doi-asserted-by":"crossref","unstructured":"F. Yu, W. Geng, P. Dong, Z. Huang, J. Zheng, LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212, Cell Death Dis. 9 (10) (2018) 1014 PMID: 30282972; PMCID: PMC6170498, doi:10.1038\/s41419-018-1068-x.","DOI":"10.1038\/s41419-018-1068-x"},{"issue":"11","key":"10.1016\/bs.acc.2022.06.001_bb0665","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.bbadis.2014.08.015","article-title":"Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis","volume":"1842","author":"He","year":"2014","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242322000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242322000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T07:57:41Z","timestamp":1753430261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242322000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323988537"],"references-count":134,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2022.06.001","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}